Biological and Immunological Evaluation of Neisseria meningitidis Serogroup A Outer Membrane Vesicle as Vaccine Candidates

authors:

avatar Seyed Ali Delbaz 1 , avatar Seyed Davar Siadat ORCID 2 , * , avatar Mohammad Reza Aghasadeghi 1 , avatar Mohamad Piryaie 3 , avatar Shahin Najar Peerayeh 4 , avatar Seyed Fazlollah Mousavi 2 , avatar Arfa Moshiri 5 , avatar Seyed Mehdi Sadat 1 , avatar Mehrangiz Zangeneh 6 , avatar Mehdi Nejati 2 , avatar Nafiseh Kashanizadeh 7 , avatar Saied Bouzari ORCID 8 , *

Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, IR Iran
Department of Microbiology, Pasteur Institute of Iran, Tehran, IR Iran
Department of Genetics, Faculty of Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
Department of Bacteriology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, IR Iran
Department of Biotechnology, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, IR Iran
Department of Infectious Diseases, Tehran Medical Branch, Islamic Azad University, Tehran, IR Iran
Department of Gynocology, Baghiat-Alah University, Tehran, IR Iran
Department of Molecular Biology, Pasteur Institute of Iran, Tehran, IR Iran
Corresponding Authors:

how to cite: Delbaz S A, Siadat S D, Aghasadeghi M R, Piryaie M, Najar Peerayeh S, et al. Biological and Immunological Evaluation of Neisseria meningitidis Serogroup A Outer Membrane Vesicle as Vaccine Candidates. Jundishapur J Microbiol.6(4):5007. doi: 10.5812/jjm.5007.

Abstract

Background:

Neisseria meningitidis Serogroup A, is a major cause of bacterial meningitidis outbreaks in Africa and the Middle East. While polysaccharide vaccines have been available for many years, these vaccines have many disadvantages including the induction of T-cell independent responses which do not induce memory responses.

Objectives:

Thus to overcome this problem, in this research outer membrane vesicle (OMV) containing PorA was extracted and evaluated by biological and immunological methods.

Materials and Methods:

OMVs were extracted with deoxycholate and EDTA, and purification was performed by sequential ultracentrifugation. Physicochemical properties of extracted OMVs were analyzed by electron microscopy and SDS-PAGE. The toxicity of LPS content in its was assayed by LAL test. The Presence of PorA as a major component of OMV was confirmed by western blot. To study antibodies synthesis after immunization with OMV, ELISA method was used. Also serum bactericidal assay (SBA) was performed to determine the serum bactericidal activity against N. meningitidis serogroup A.

Results:

The results revealed that the content of protein extracted was 0.1 mg/mL. The electron microscopy showed that intactness of the vesicle in these preparation ranged more than 70%. The SDS-PAGE showed that PorA as a major immunological part of outer membrane vesicle was located in 35-40kDa. LAL test showed that the endotoxin activity was around 126EU/mL which is safe for using. The ELISA test revealed that the IgG total titer was elevated after the first injection. SBA indicates that bactericidal antibodies rise after the second dose of booster.

Conclusions:

The results showed that the extracted OMVs were conformationally stable, and there were no pyrogenic determinants in OMV. Also the results showed that the OMV elicited high level of specific antibodies against N. meningitidis serogroup A. These results indicate that the OMV obtained here, can be used as a meningococcal vaccine after further investigation.

Full Text

Full text is available in PDF

© 2013, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.